Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency

The objective of the study was the characterization of ABCA1 gene mutations in 10 patients with extremely low HDL-cholesterol. Five patients (aged 6months to 76years) presented with splenomegaly and thrombocytopenia suggesting the diagnosis of Tangier disease (TD). Three of them were homozygous for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular genetics and metabolism 2012-11, Vol.107 (3), p.534-541
Hauptverfasser: Fasano, Tommaso, Zanoni, Paolo, Rabacchi, Claudio, Pisciotta, Livia, Favari, Elda, Adorni, Maria Pia, Deegan, Patrick B., Park, Adrian, Hlaing, Thinn, Feher, Michael D., Jones, Ben, Uzak, Asli Subasioglu, Kardas, Fatih, Dardis, Andrea, Sechi, Annalisa, Bembi, Bruno, Minuz, Pietro, Bertolini, Stefano, Bernini, Franco, Calandra, Sebastiano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 541
container_issue 3
container_start_page 534
container_title Molecular genetics and metabolism
container_volume 107
creator Fasano, Tommaso
Zanoni, Paolo
Rabacchi, Claudio
Pisciotta, Livia
Favari, Elda
Adorni, Maria Pia
Deegan, Patrick B.
Park, Adrian
Hlaing, Thinn
Feher, Michael D.
Jones, Ben
Uzak, Asli Subasioglu
Kardas, Fatih
Dardis, Andrea
Sechi, Annalisa
Bembi, Bruno
Minuz, Pietro
Bertolini, Stefano
Bernini, Franco
Calandra, Sebastiano
description The objective of the study was the characterization of ABCA1 gene mutations in 10 patients with extremely low HDL-cholesterol. Five patients (aged 6months to 76years) presented with splenomegaly and thrombocytopenia suggesting the diagnosis of Tangier disease (TD). Three of them were homozygous for novel mutations either in intron (c.4465-34A>G) or in exons (c.4376delT and c.5449C>T), predicted to encode truncated proteins. One patient was compound heterozygous for a nucleotide insertion (c.1758_1759insG), resulting in a truncated protein and for a nucleotide substitution c.4799A>G, resulting in a missense mutation (p.H1600R). The last TD patient, found to be heterozygous for a known mutation (p.D1009Y), had a complete defect in ABCA1-mediated cholesterol efflux in fibroblasts, suggesting the presence of a second undetected mutant allele. Among the other patients, four were asymptomatic, but one, with multiple risk factors, had severe peripheral artery disease. Three of these patients were heterozygous for known mutations (p.R130K+p.N1800H, p.R1068C, p.N1800H), while two were carriers of novel mutations (c.1195-27G>A and c.396_397insA), predicted to encode truncated proteins. The pathogenic effect of the two intronic mutations (c. 1195-27G>A and c.4465-34A>G) was demonstrated by the analysis of the transcripts of splicing reporter mutant minigenes expressed in COS-1 cells. Both mutations activated an intronic acceptor splice site which resulted in a partial intron retention in mature mRNA with the production of truncated proteins. This study confirms the allelic heterogeneity of TD and suggests that the diagnosis of TD must be considered in patients with an unexplained splenomegaly, associated with thrombocytopenia and hypocholesterolemia. ► ABCA1 mutations were identified in 10 patients with low plasma HDL-C levels. ► Five patients had Tangier disease and five had Familial HDL deficiency. ► Seven novel ABCA1 mutations were identified: 5 in exons and 2 in introns. ► The exonic mutations produced deleterious missense or nonsense mutations. ► The intronic mutations generated abnormally spliced mRNA encoding truncated proteins.
doi_str_mv 10.1016/j.ymgme.2012.08.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1272719115</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1096719212003058</els_id><sourcerecordid>1272719115</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-1bc6fb7b697997b24841d81a35931c53183330fa14679f142f0e71e90e7c9f5c3</originalsourceid><addsrcrecordid>eNqFkUtvGyEURlGVqHbc_oJKEctsPOHCvFhk4bp5VLLSjbtGDHNJsebhAk7lfx8S21mmG0C65-NK5yPkG7AMGJTXm2zfP_WYcQY8Y3XGWPGJTIHJcl5xVp6d3iD5hFyEsGEMoJD5ZzLhXBay5vWU6MfxGTva76KObhwCHS1dfF8ugEavh7AdfURP3UC3aY5DDPSfi3_oWg9PLg1aF1AHpHpoqdW965zu6MOPFW3ROpMCZv-FnFvdBfx6vGfk993tevkwX_26_7lcrOZGSB7n0JjSNlVTykrKquF5nUNbgxaFFGAKAbUQglkNeVlJCzm3DCtAmU4jbWHEjFwd_t368e8OQ1S9Cwa7Tg847oICXvHkIin4Pwqcl6ziwBMqDqjxYwgerdp612u_V8DUaw1qo95qUK81KFarVENKXR4X7Joe2_fMyXsCbg4AJiPPyaQKb7awdR5NVO3oPlzwArpZmF0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1122607212</pqid></control><display><type>article</type><title>Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Fasano, Tommaso ; Zanoni, Paolo ; Rabacchi, Claudio ; Pisciotta, Livia ; Favari, Elda ; Adorni, Maria Pia ; Deegan, Patrick B. ; Park, Adrian ; Hlaing, Thinn ; Feher, Michael D. ; Jones, Ben ; Uzak, Asli Subasioglu ; Kardas, Fatih ; Dardis, Andrea ; Sechi, Annalisa ; Bembi, Bruno ; Minuz, Pietro ; Bertolini, Stefano ; Bernini, Franco ; Calandra, Sebastiano</creator><creatorcontrib>Fasano, Tommaso ; Zanoni, Paolo ; Rabacchi, Claudio ; Pisciotta, Livia ; Favari, Elda ; Adorni, Maria Pia ; Deegan, Patrick B. ; Park, Adrian ; Hlaing, Thinn ; Feher, Michael D. ; Jones, Ben ; Uzak, Asli Subasioglu ; Kardas, Fatih ; Dardis, Andrea ; Sechi, Annalisa ; Bembi, Bruno ; Minuz, Pietro ; Bertolini, Stefano ; Bernini, Franco ; Calandra, Sebastiano</creatorcontrib><description>The objective of the study was the characterization of ABCA1 gene mutations in 10 patients with extremely low HDL-cholesterol. Five patients (aged 6months to 76years) presented with splenomegaly and thrombocytopenia suggesting the diagnosis of Tangier disease (TD). Three of them were homozygous for novel mutations either in intron (c.4465-34A&gt;G) or in exons (c.4376delT and c.5449C&gt;T), predicted to encode truncated proteins. One patient was compound heterozygous for a nucleotide insertion (c.1758_1759insG), resulting in a truncated protein and for a nucleotide substitution c.4799A&gt;G, resulting in a missense mutation (p.H1600R). The last TD patient, found to be heterozygous for a known mutation (p.D1009Y), had a complete defect in ABCA1-mediated cholesterol efflux in fibroblasts, suggesting the presence of a second undetected mutant allele. Among the other patients, four were asymptomatic, but one, with multiple risk factors, had severe peripheral artery disease. Three of these patients were heterozygous for known mutations (p.R130K+p.N1800H, p.R1068C, p.N1800H), while two were carriers of novel mutations (c.1195-27G&gt;A and c.396_397insA), predicted to encode truncated proteins. The pathogenic effect of the two intronic mutations (c. 1195-27G&gt;A and c.4465-34A&gt;G) was demonstrated by the analysis of the transcripts of splicing reporter mutant minigenes expressed in COS-1 cells. Both mutations activated an intronic acceptor splice site which resulted in a partial intron retention in mature mRNA with the production of truncated proteins. This study confirms the allelic heterogeneity of TD and suggests that the diagnosis of TD must be considered in patients with an unexplained splenomegaly, associated with thrombocytopenia and hypocholesterolemia. ► ABCA1 mutations were identified in 10 patients with low plasma HDL-C levels. ► Five patients had Tangier disease and five had Familial HDL deficiency. ► Seven novel ABCA1 mutations were identified: 5 in exons and 2 in introns. ► The exonic mutations produced deleterious missense or nonsense mutations. ► The intronic mutations generated abnormally spliced mRNA encoding truncated proteins.</description><identifier>ISSN: 1096-7192</identifier><identifier>EISSN: 1096-7206</identifier><identifier>DOI: 10.1016/j.ymgme.2012.08.005</identifier><identifier>PMID: 22959828</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>ABCA1 gene ; Adult ; Aged ; Animals ; ATP Binding Cassette Transporter 1 ; ATP-Binding Cassette Transporters - genetics ; ATP-Binding Cassette Transporters - metabolism ; Cell cholesterol efflux ; Cercopithecus aethiops ; Child ; Cholesterol, HDL - deficiency ; COS Cells ; Exons ; Female ; Heterozygote ; High density lipoprotein cholesterol ; Homozygote ; Humans ; Hypoalphalipoproteinemias - genetics ; Hypoalphalipoproteinemias - metabolism ; Hypoalphalipoproteinemias - pathology ; Infant ; Introns ; Male ; Mutation ; Pedigree ; RNA Splice Sites ; RNA Splicing ; RNA, Messenger - genetics ; Tangier disease ; Tangier Disease - genetics ; Tangier Disease - metabolism ; Tangier Disease - pathology</subject><ispartof>Molecular genetics and metabolism, 2012-11, Vol.107 (3), p.534-541</ispartof><rights>2012 Elsevier Inc.</rights><rights>Copyright © 2012 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-1bc6fb7b697997b24841d81a35931c53183330fa14679f142f0e71e90e7c9f5c3</citedby><cites>FETCH-LOGICAL-c392t-1bc6fb7b697997b24841d81a35931c53183330fa14679f142f0e71e90e7c9f5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ymgme.2012.08.005$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22959828$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fasano, Tommaso</creatorcontrib><creatorcontrib>Zanoni, Paolo</creatorcontrib><creatorcontrib>Rabacchi, Claudio</creatorcontrib><creatorcontrib>Pisciotta, Livia</creatorcontrib><creatorcontrib>Favari, Elda</creatorcontrib><creatorcontrib>Adorni, Maria Pia</creatorcontrib><creatorcontrib>Deegan, Patrick B.</creatorcontrib><creatorcontrib>Park, Adrian</creatorcontrib><creatorcontrib>Hlaing, Thinn</creatorcontrib><creatorcontrib>Feher, Michael D.</creatorcontrib><creatorcontrib>Jones, Ben</creatorcontrib><creatorcontrib>Uzak, Asli Subasioglu</creatorcontrib><creatorcontrib>Kardas, Fatih</creatorcontrib><creatorcontrib>Dardis, Andrea</creatorcontrib><creatorcontrib>Sechi, Annalisa</creatorcontrib><creatorcontrib>Bembi, Bruno</creatorcontrib><creatorcontrib>Minuz, Pietro</creatorcontrib><creatorcontrib>Bertolini, Stefano</creatorcontrib><creatorcontrib>Bernini, Franco</creatorcontrib><creatorcontrib>Calandra, Sebastiano</creatorcontrib><title>Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency</title><title>Molecular genetics and metabolism</title><addtitle>Mol Genet Metab</addtitle><description>The objective of the study was the characterization of ABCA1 gene mutations in 10 patients with extremely low HDL-cholesterol. Five patients (aged 6months to 76years) presented with splenomegaly and thrombocytopenia suggesting the diagnosis of Tangier disease (TD). Three of them were homozygous for novel mutations either in intron (c.4465-34A&gt;G) or in exons (c.4376delT and c.5449C&gt;T), predicted to encode truncated proteins. One patient was compound heterozygous for a nucleotide insertion (c.1758_1759insG), resulting in a truncated protein and for a nucleotide substitution c.4799A&gt;G, resulting in a missense mutation (p.H1600R). The last TD patient, found to be heterozygous for a known mutation (p.D1009Y), had a complete defect in ABCA1-mediated cholesterol efflux in fibroblasts, suggesting the presence of a second undetected mutant allele. Among the other patients, four were asymptomatic, but one, with multiple risk factors, had severe peripheral artery disease. Three of these patients were heterozygous for known mutations (p.R130K+p.N1800H, p.R1068C, p.N1800H), while two were carriers of novel mutations (c.1195-27G&gt;A and c.396_397insA), predicted to encode truncated proteins. The pathogenic effect of the two intronic mutations (c. 1195-27G&gt;A and c.4465-34A&gt;G) was demonstrated by the analysis of the transcripts of splicing reporter mutant minigenes expressed in COS-1 cells. Both mutations activated an intronic acceptor splice site which resulted in a partial intron retention in mature mRNA with the production of truncated proteins. This study confirms the allelic heterogeneity of TD and suggests that the diagnosis of TD must be considered in patients with an unexplained splenomegaly, associated with thrombocytopenia and hypocholesterolemia. ► ABCA1 mutations were identified in 10 patients with low plasma HDL-C levels. ► Five patients had Tangier disease and five had Familial HDL deficiency. ► Seven novel ABCA1 mutations were identified: 5 in exons and 2 in introns. ► The exonic mutations produced deleterious missense or nonsense mutations. ► The intronic mutations generated abnormally spliced mRNA encoding truncated proteins.</description><subject>ABCA1 gene</subject><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>ATP Binding Cassette Transporter 1</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>ATP-Binding Cassette Transporters - metabolism</subject><subject>Cell cholesterol efflux</subject><subject>Cercopithecus aethiops</subject><subject>Child</subject><subject>Cholesterol, HDL - deficiency</subject><subject>COS Cells</subject><subject>Exons</subject><subject>Female</subject><subject>Heterozygote</subject><subject>High density lipoprotein cholesterol</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Hypoalphalipoproteinemias - genetics</subject><subject>Hypoalphalipoproteinemias - metabolism</subject><subject>Hypoalphalipoproteinemias - pathology</subject><subject>Infant</subject><subject>Introns</subject><subject>Male</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>RNA Splice Sites</subject><subject>RNA Splicing</subject><subject>RNA, Messenger - genetics</subject><subject>Tangier disease</subject><subject>Tangier Disease - genetics</subject><subject>Tangier Disease - metabolism</subject><subject>Tangier Disease - pathology</subject><issn>1096-7192</issn><issn>1096-7206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtvGyEURlGVqHbc_oJKEctsPOHCvFhk4bp5VLLSjbtGDHNJsebhAk7lfx8S21mmG0C65-NK5yPkG7AMGJTXm2zfP_WYcQY8Y3XGWPGJTIHJcl5xVp6d3iD5hFyEsGEMoJD5ZzLhXBay5vWU6MfxGTva76KObhwCHS1dfF8ugEavh7AdfURP3UC3aY5DDPSfi3_oWg9PLg1aF1AHpHpoqdW965zu6MOPFW3ROpMCZv-FnFvdBfx6vGfk993tevkwX_26_7lcrOZGSB7n0JjSNlVTykrKquF5nUNbgxaFFGAKAbUQglkNeVlJCzm3DCtAmU4jbWHEjFwd_t368e8OQ1S9Cwa7Tg847oICXvHkIin4Pwqcl6ziwBMqDqjxYwgerdp612u_V8DUaw1qo95qUK81KFarVENKXR4X7Joe2_fMyXsCbg4AJiPPyaQKb7awdR5NVO3oPlzwArpZmF0</recordid><startdate>201211</startdate><enddate>201211</enddate><creator>Fasano, Tommaso</creator><creator>Zanoni, Paolo</creator><creator>Rabacchi, Claudio</creator><creator>Pisciotta, Livia</creator><creator>Favari, Elda</creator><creator>Adorni, Maria Pia</creator><creator>Deegan, Patrick B.</creator><creator>Park, Adrian</creator><creator>Hlaing, Thinn</creator><creator>Feher, Michael D.</creator><creator>Jones, Ben</creator><creator>Uzak, Asli Subasioglu</creator><creator>Kardas, Fatih</creator><creator>Dardis, Andrea</creator><creator>Sechi, Annalisa</creator><creator>Bembi, Bruno</creator><creator>Minuz, Pietro</creator><creator>Bertolini, Stefano</creator><creator>Bernini, Franco</creator><creator>Calandra, Sebastiano</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201211</creationdate><title>Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency</title><author>Fasano, Tommaso ; Zanoni, Paolo ; Rabacchi, Claudio ; Pisciotta, Livia ; Favari, Elda ; Adorni, Maria Pia ; Deegan, Patrick B. ; Park, Adrian ; Hlaing, Thinn ; Feher, Michael D. ; Jones, Ben ; Uzak, Asli Subasioglu ; Kardas, Fatih ; Dardis, Andrea ; Sechi, Annalisa ; Bembi, Bruno ; Minuz, Pietro ; Bertolini, Stefano ; Bernini, Franco ; Calandra, Sebastiano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-1bc6fb7b697997b24841d81a35931c53183330fa14679f142f0e71e90e7c9f5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>ABCA1 gene</topic><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>ATP Binding Cassette Transporter 1</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>ATP-Binding Cassette Transporters - metabolism</topic><topic>Cell cholesterol efflux</topic><topic>Cercopithecus aethiops</topic><topic>Child</topic><topic>Cholesterol, HDL - deficiency</topic><topic>COS Cells</topic><topic>Exons</topic><topic>Female</topic><topic>Heterozygote</topic><topic>High density lipoprotein cholesterol</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Hypoalphalipoproteinemias - genetics</topic><topic>Hypoalphalipoproteinemias - metabolism</topic><topic>Hypoalphalipoproteinemias - pathology</topic><topic>Infant</topic><topic>Introns</topic><topic>Male</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>RNA Splice Sites</topic><topic>RNA Splicing</topic><topic>RNA, Messenger - genetics</topic><topic>Tangier disease</topic><topic>Tangier Disease - genetics</topic><topic>Tangier Disease - metabolism</topic><topic>Tangier Disease - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fasano, Tommaso</creatorcontrib><creatorcontrib>Zanoni, Paolo</creatorcontrib><creatorcontrib>Rabacchi, Claudio</creatorcontrib><creatorcontrib>Pisciotta, Livia</creatorcontrib><creatorcontrib>Favari, Elda</creatorcontrib><creatorcontrib>Adorni, Maria Pia</creatorcontrib><creatorcontrib>Deegan, Patrick B.</creatorcontrib><creatorcontrib>Park, Adrian</creatorcontrib><creatorcontrib>Hlaing, Thinn</creatorcontrib><creatorcontrib>Feher, Michael D.</creatorcontrib><creatorcontrib>Jones, Ben</creatorcontrib><creatorcontrib>Uzak, Asli Subasioglu</creatorcontrib><creatorcontrib>Kardas, Fatih</creatorcontrib><creatorcontrib>Dardis, Andrea</creatorcontrib><creatorcontrib>Sechi, Annalisa</creatorcontrib><creatorcontrib>Bembi, Bruno</creatorcontrib><creatorcontrib>Minuz, Pietro</creatorcontrib><creatorcontrib>Bertolini, Stefano</creatorcontrib><creatorcontrib>Bernini, Franco</creatorcontrib><creatorcontrib>Calandra, Sebastiano</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Molecular genetics and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fasano, Tommaso</au><au>Zanoni, Paolo</au><au>Rabacchi, Claudio</au><au>Pisciotta, Livia</au><au>Favari, Elda</au><au>Adorni, Maria Pia</au><au>Deegan, Patrick B.</au><au>Park, Adrian</au><au>Hlaing, Thinn</au><au>Feher, Michael D.</au><au>Jones, Ben</au><au>Uzak, Asli Subasioglu</au><au>Kardas, Fatih</au><au>Dardis, Andrea</au><au>Sechi, Annalisa</au><au>Bembi, Bruno</au><au>Minuz, Pietro</au><au>Bertolini, Stefano</au><au>Bernini, Franco</au><au>Calandra, Sebastiano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency</atitle><jtitle>Molecular genetics and metabolism</jtitle><addtitle>Mol Genet Metab</addtitle><date>2012-11</date><risdate>2012</risdate><volume>107</volume><issue>3</issue><spage>534</spage><epage>541</epage><pages>534-541</pages><issn>1096-7192</issn><eissn>1096-7206</eissn><abstract>The objective of the study was the characterization of ABCA1 gene mutations in 10 patients with extremely low HDL-cholesterol. Five patients (aged 6months to 76years) presented with splenomegaly and thrombocytopenia suggesting the diagnosis of Tangier disease (TD). Three of them were homozygous for novel mutations either in intron (c.4465-34A&gt;G) or in exons (c.4376delT and c.5449C&gt;T), predicted to encode truncated proteins. One patient was compound heterozygous for a nucleotide insertion (c.1758_1759insG), resulting in a truncated protein and for a nucleotide substitution c.4799A&gt;G, resulting in a missense mutation (p.H1600R). The last TD patient, found to be heterozygous for a known mutation (p.D1009Y), had a complete defect in ABCA1-mediated cholesterol efflux in fibroblasts, suggesting the presence of a second undetected mutant allele. Among the other patients, four were asymptomatic, but one, with multiple risk factors, had severe peripheral artery disease. Three of these patients were heterozygous for known mutations (p.R130K+p.N1800H, p.R1068C, p.N1800H), while two were carriers of novel mutations (c.1195-27G&gt;A and c.396_397insA), predicted to encode truncated proteins. The pathogenic effect of the two intronic mutations (c. 1195-27G&gt;A and c.4465-34A&gt;G) was demonstrated by the analysis of the transcripts of splicing reporter mutant minigenes expressed in COS-1 cells. Both mutations activated an intronic acceptor splice site which resulted in a partial intron retention in mature mRNA with the production of truncated proteins. This study confirms the allelic heterogeneity of TD and suggests that the diagnosis of TD must be considered in patients with an unexplained splenomegaly, associated with thrombocytopenia and hypocholesterolemia. ► ABCA1 mutations were identified in 10 patients with low plasma HDL-C levels. ► Five patients had Tangier disease and five had Familial HDL deficiency. ► Seven novel ABCA1 mutations were identified: 5 in exons and 2 in introns. ► The exonic mutations produced deleterious missense or nonsense mutations. ► The intronic mutations generated abnormally spliced mRNA encoding truncated proteins.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22959828</pmid><doi>10.1016/j.ymgme.2012.08.005</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1096-7192
ispartof Molecular genetics and metabolism, 2012-11, Vol.107 (3), p.534-541
issn 1096-7192
1096-7206
language eng
recordid cdi_proquest_miscellaneous_1272719115
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects ABCA1 gene
Adult
Aged
Animals
ATP Binding Cassette Transporter 1
ATP-Binding Cassette Transporters - genetics
ATP-Binding Cassette Transporters - metabolism
Cell cholesterol efflux
Cercopithecus aethiops
Child
Cholesterol, HDL - deficiency
COS Cells
Exons
Female
Heterozygote
High density lipoprotein cholesterol
Homozygote
Humans
Hypoalphalipoproteinemias - genetics
Hypoalphalipoproteinemias - metabolism
Hypoalphalipoproteinemias - pathology
Infant
Introns
Male
Mutation
Pedigree
RNA Splice Sites
RNA Splicing
RNA, Messenger - genetics
Tangier disease
Tangier Disease - genetics
Tangier Disease - metabolism
Tangier Disease - pathology
title Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T17%3A16%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20mutations%20of%20ABCA1%20transporter%20in%20patients%20with%20Tangier%20disease%20and%20familial%20HDL%20deficiency&rft.jtitle=Molecular%20genetics%20and%20metabolism&rft.au=Fasano,%20Tommaso&rft.date=2012-11&rft.volume=107&rft.issue=3&rft.spage=534&rft.epage=541&rft.pages=534-541&rft.issn=1096-7192&rft.eissn=1096-7206&rft_id=info:doi/10.1016/j.ymgme.2012.08.005&rft_dat=%3Cproquest_cross%3E1272719115%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1122607212&rft_id=info:pmid/22959828&rft_els_id=S1096719212003058&rfr_iscdi=true